FdaApplication
ANDA 213912
Identifiers
- fda_app_no: ANDA213912
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2022-08-30 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LENALIDOMIDE | LENALIDOMIDE | 15MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 5MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 25MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 10MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 2.5MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 20MG | CAPSULE;ORAL |
6 products